Act 637, SB 387 – TO AUTHORIZE OFF-LABEL USE OF DRUG TREATMENTS TO TREAT MEDICAID BENEFICIARIES WITH PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION

Session2021 Regular Session
Year2021
Enactment Date12 April 2021
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT